Home » Topics » BioWorld Science

BioWorld Science
RSS

Topline results announced from phase I study of ZYN-001 THC-prodrug patch

July 6, 2018

MR-438 peptidomimetic presented as a new radiosensitizing agent in medulloblastoma

July 6, 2018

[89]Zr-DFO-dinutuximab as novel radiotracer for selective detection of GD2-positive tumors

July 6, 2018

NOVA2 or DDX6 mutations alter RNA metabolism leading to intellectual disability

July 6, 2018

Serum netrin-1, a potential early biomarker for impaired fasting glucose and type 2 diabetes

July 6, 2018

CYP11B1 enzyme, a potential predictive biomarker for healing failure in diabetic foot ulcers

July 6, 2018

CB-4211 potentiates insulin effects on fatty acid metabolism and glucose homeostasis

July 6, 2018

IDMC clears phase III study of Tedopi in NSCLC to continue

July 5, 2018

Phase II study of pacritinib in myelofibrosis cleared to continue by IDMC

July 5, 2018

Immutep submits IND to begin phase II study of eftilagimod with Keytruda

July 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...